Cat. No. 5077
Chemical Name: N-[3-[(2,3-Dihydro-2-oxo-1H-indol-5
Biological ActivitySelective discoidin domain receptor 1 (DDR1) tyrosine kinase inhibitor (IC50 values are 105 and 413 nM for DDR1 and DDR2 respectively). Inhibits integrin-induced DDR1 autophosphorylation in an osteosarcoma cell line.
External Portal InformationChemicalprobes.org is a portal that offers independent guidance on the selection and/or application of small molecules for research. The use of DDR1-IN-1 is reviewed on the chemical probes website.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Canning et al (2014) Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors. J.Mol.Biol. 426 2457. PMID: 24768818.
Kim et al (2013) Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor. ACS.Chem.Biol. 8 2145. PMID: 23899692.
If you know of a relevant reference for DDR1-IN-1 dihydrochloride please let us know.
Citations are publications that use Tocris products. Selected citations for DDR1-IN-1 dihydrochloride include:
Malaguarnera et al (2015) Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses. BMC Complement Altern Med 6 16084. PMID: 25840417.
Do you know of a great paper that uses DDR1-IN-1 dihydrochloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: DDR1-IN-1 dihydrochloride, supplier, selective, discoidin, domain, receptors, DDR1, DDR2, tyrosine, kinases, Tocris Bioscience, Other RTKs Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective PDGFR inhibitorGSK 1363089
Potent inhibitor of MET, VEGFR2, Ron and AXLPF 06273340
Potent and selective pan-Trk inhibitor; peripherally restricted
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.